Cellular Senescence – Definition, Causes and Treatment

What Is Cellular Senescence?

Cellular senescence (from the Latin senescere, meaning to grow old) is a biological state in which body cells permanently cease to divide without dying. These senescent cells remain metabolically active but undergo fundamental changes in their behavior and function. The phenomenon was first described in the 1960s by cell biologists Leonard Hayflick and Paul Moorhead and has since become a central field of research in aging biology and oncology.

Causes of Cellular Senescence

Cellular senescence can be triggered by a variety of internal and external factors:

• Telomere shortening: With each cell division, the protective caps at the ends of chromosomes, known as telomeres, become shorter. When they reach a critically short length, the cell is forced into senescence.
• DNA damage: Oxidative stress, UV radiation, ionizing radiation, or toxic chemical exposures can damage DNA and trigger a senescence response.
• Oncogene activation: The abnormal activation of growth-promoting genes (oncogenes) can paradoxically induce senescence as a protective mechanism to prevent uncontrolled cell proliferation.
• Epigenetic alterations: Changes in gene regulation that do not involve the DNA sequence itself can also initiate senescence.

Mechanism of Action and Biological Significance

Senescent cells display characteristic molecular features. They activate the p53/p21 signaling pathway or the p16/Rb signaling pathway, both of which permanently block the cell cycle. In addition, senescent cells secrete a wide range of signaling molecules including cytokines, chemokines, and matrix metalloproteinases. This secretory profile is known as the SASP (Senescence-Associated Secretory Phenotype).

The SASP has a dual-edged effect:

• Short-term protective: SASP signals recruit immune cells to clear senescent cells and support wound healing and tissue regeneration.
• Long-term harmful: When senescent cells accumulate and are not efficiently cleared, the resulting chronic inflammatory state (known as inflammaging) promotes tissue dysfunction, accelerated aging, and the development of disease.

Cellular Senescence and Disease

The accumulation of senescent cells is linked to numerous age-related conditions:

• Cancer: Senescence acts as a tumor suppressor on one hand, but the SASP can also promote the tumor microenvironment and contribute to malignant transformation of neighboring cells.
• Cardiovascular disease: Senescent cells in vessel walls promote atherosclerosis and hypertension.
• Neurodegenerative diseases: Accumulating senescent cells in the brain have been associated with Alzheimer's disease and Parkinson's disease.
• Metabolic syndrome: Senescent fat and liver cells influence insulin sensitivity and promote systemic inflammation.
• Osteoporosis and muscle loss: Senescent bone and muscle cells contribute to age-related deterioration of the musculoskeletal system.

Diagnosis and Detection Methods

Detection of cellular senescence in research is performed using several established markers:

• Beta-galactosidase activity: The enzyme SA-beta-Gal (senescence-associated beta-galactosidase) is a classic marker of cellular senescence.
• p16INK4a expression: This tumor suppressor protein is strongly upregulated in senescent cells and serves as a reliable biomarker.
• DNA damage foci: Clusters of DNA repair proteins at chromosomal breaks are visible under microscopy.
• SASP profile: Measuring inflammatory mediators in blood or tissue provides an indication of the overall senescent cell burden.

Therapeutic Approaches: Senolytics and Senomorphics

The targeted modulation of senescent cells is a highly promising area of research:

Senolytics

Senolytics are compounds that selectively eliminate senescent cells. Among the best-known experimental senolytics are dasatinib (an anticancer drug) combined with the plant-derived compound quercetin, as well as navitoclax. Clinical trials are currently investigating their use in age-related conditions such as pulmonary fibrosis, osteoporosis, and chronic kidney disease.

Senomorphics

Senomorphics do not target the senescent cells themselves but instead suppress their harmful SASP. The aim is to reduce chronic inflammation without eliminating the protective functions of senescence. Well-known candidates include rapamycin (an mTOR inhibitor) and certain JAK inhibitors.

Cellular Senescence as a Protective Function

It is important to understand that cellular senescence is not exclusively harmful. It serves as a critical tumor suppressor by preventing damaged cells from proliferating uncontrollably and becoming cancerous. It also plays an essential role in normal embryonic development, wound healing, and tissue homeostasis. The therapeutic goal is therefore not the complete elimination of senescence, but rather the management of its negative consequences during aging.

References

1. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Experimental Cell Research. 1961;25(3):585-621.
2. Campisi J. Aging, Cellular Senescence, and Cancer. Annual Review of Physiology. 2013;75:685-705. PubMed PMID: 23140366.
3. van Deursen JM. The role of senescent cells in ageing. Nature. 2014;509(7501):439-446. DOI: 10.1038/nature13193.